Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-12

FDA Approved: VIGABATRIN — Supplemental Application (Dr. Reddys Laboratories Inc.,)

View source ↗

Summary

FDA approved a supplemental application for Vigabatrin submitted by Dr. Reddy's Laboratories Inc., enabling continued availability of the generic product under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)